Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.53 |
| ▸ | GRM5 | P41594 | 5/20 | 0.48 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.46 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | GCK | P35557 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5202506 | 0.84 | PDE10A (0.56) | PDE10AGRM5NPC1RAB9A | |
| SCHEMBL15664001 | 0.82 | PDE4B (0.40) | PDE10AGRM5PDE4BPDE4DNPC1 | |
| SCHEMBL5202081 | 0.82 | PDE10A (0.63) | PDE10AGRM5NPC1RAB9ANOTUM | |
| SCHEMBL5208137 | 0.82 | GRM5 (0.72) | PDE10AGRM5NPC1RAB9A | |
| SCHEMBL5265918 | 0.81 | PDE10A (0.54) | PDE10AGRM5NPC1RAB9A | |
| SCHEMBL5203611 | 0.78 | PDE10A (0.53) | PDE10AGRM5NPC1RAB9A | |
| SCHEMBL5200903 | 0.77 | PDE10A (0.55) | PDE10AGRM5NPC1RAB9A | |
| SCHEMBL5204996 | 0.77 | GRM5 (0.49) | PDE10AGRM5NPC1RAB9A | |
| SCHEMBL5204946 | 0.77 | PDE10A (0.52) | PDE10AGRM5NPC1RAB9AKCNH2 | |
| SCHEMBL4905436 | 0.76 | KDM4E (0.42) | PDE10AGRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1858854-A1 | PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MGLUR5 ANTAGONISTS | F. Hoffmann-La Roche AG (CH) | 2007-11-28 | — | — | EP | claimed |
| WO-2006094639-A1 | PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MGLUR5 ANTAGONISTS | F.HOFFMANN-LA ROCHE AG (CH) | 2006-09-14 | — | — | WO | claimed |